{"id":"CHEMBL1044","canonicalSmiles":"O=C(O)Cc1ccccc1","inchiKey":"WLJVXDMOQOGPHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buphenyl","Phenylacetate"],"crossReferences":{"PubChem":["144206593","144207731","170465102","418014"],"Wikipedia":["Phenylacetic_acid"],"drugbank":["DB09269"],"chEBI":["30745"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1076257","canonicalSmiles":"Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F","inchiKey":"IDYKCXHJJGMAEV-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1076257","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12957"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL109341","canonicalSmiles":"COc1cc(/C=C/C(=O)O)cc(OC)c1O","inchiKey":"PCMORTLOPMLEFB-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SINAPINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sinapic Acid"],"crossReferences":{"PubChem":["47193735"],"Wikipedia":["Sinapinic_acid"],"drugbank":["DB08587"],"chEBI":["15714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1096927","canonicalSmiles":"CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)CC1","inchiKey":"RGZSQWQPBWRIAQ-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMENOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-.alpha.-bisabolol","(.alpha.s,1s)-.alpha.-bisabolol",".alpha.-bisabolol",".alpha.-bisabolol (-)-form",".alpha.-bisabolol, (-)-","Alpha-(-)-bisabolol","Alpha-Bisabolol","Bisabolol","Bisabolol, (-)-.alpha.","FEMA NO. 4666","Kamillosan","Levomenol"],"crossReferences":{"PubChem":["144211692"],"drugbank":["DB13153"],"chEBI":["125"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1167","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12","inchiKey":"UNFWWIHTNXNPBV-WXKVUWSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPECTINOMYCIN","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Actinospectacin","Adspec","CHX-3101","Prospec","Spectinomycin","Trobicin"],"crossReferences":{"PubChem":["26754323"],"Wikipedia":["Spectinomycin"],"drugbank":["DB00919"],"chEBI":["9215"]},"childChemblIds":["CHEMBL1443447","CHEMBL1969020","CHEMBL4543601","CHEMBL3184600","CHEMBL1200407","CHEMBL3989571"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1200370","canonicalSmiles":"O=C(OOC(=O)c1ccccc1)c1ccccc1","inchiKey":"OMPJBNCRMGITSC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOYL PEROXIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetoxyl 2.5","Acetoxyl 5","Acne-aid cream","Acnecide","Acnecide 10","Acnegel","Acnegel fte","Acnidazil","Benoxyl","Benoxyl 10","Benoxyl 20","Benoxyl 5","Benzac","Benzac w","Benzagel 10","Benzagel 5","Benzamycin","Brevoxyl","Clear by design","Clearasil max 10","Dermoxyl","Dry and clear","Dry clear","Epi-clear","Fostex bpo bar, gel, and wash","Gppe lotio gel","Loroxide","Mediclear","Mediclear acne 10","Mediclear acne 5","Nericur","Oxy-10","Oxy-10 cover-up","Oxy-5","Panoxyl","Panoxyl 10","Panoxyl 10 acnegel","Panoxyl 10 aquagel","Panoxyl 2.5 aquagel","Panoxyl 5 acnegel","Panoxyl 5 aquagel","Panoxyl crm 5","Panoxyl lot 10","Panoxyl lot 5","Persa-gel","Quinoderm 5","Quinoped","Theraderm 10","Theraderm 5","Topex","Ultra clearasil","Valderma","Vanair","Vanoxide"],"synonyms":["Anhydrous benzoyl peroxide","Benzoyl peroxide","Benzoyl peroxide anhydrous","Benzoyl superoxide","Benzoylis peroxidum cum aqua","E-928","E928","Hydrous benzoyl peroxide","Ins no.928","Ins-928","NSC-671","NSC-675"],"crossReferences":{"DailyMed":["benzoyl%20peroxide"],"PubChem":["170464986","26754472","29215306"],"Wikipedia":["Benzoyl_peroxide"],"drugbank":["DB09096"],"chEBI":["82405"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for acne and has 2 investigational indications."}
{"id":"CHEMBL1200813","canonicalSmiles":"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1.Cl","inchiKey":"KTUFKADDDORSSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEBUTOLOL HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL642","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acebut hcl","Acebutolol hydrochloride","Sectral","Sectral 200","Sectral 400"],"synonyms":["Acebutolol hcl","Acebutolol hydrochloride","Acetanol","B 17803A","B-17803A","IL-17803A","M&B 17803A","M&B-17803A","NSC-757412","Neptal","Prent"],"crossReferences":{"DailyMed":["acebutolol%20hydrochloride"],"PubChem":["144204184","170465309","56424136","855517"],"chEBI":["2380"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["HP_0004308","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for ventricular arrhythmia and hypertension."}
{"id":"CHEMBL1200822","canonicalSmiles":"CC(=O)O.O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F","inchiKey":"RKXNZRPQSOPPRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLECAINIDE ACETATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL652","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flecainide acetate","Tambocor"],"synonyms":["Flecainide acetate","Flecainide monoacetate"],"crossReferences":{"DailyMed":["flecainide%20acetate"],"PubChem":["144207406","50106340","56422486","855927"],"chEBI":["5091"]},"linkedTargets":{"rows":["ENSG00000183873"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","HP_0004308","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for ventricular arrhythmia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200948","canonicalSmiles":"CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\\C(=O)O","inchiKey":"YDGHCKHAXOUQOS-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIMIPRAMINE MALEATE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL644","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Surmontil","Trimipramine maleate"],"synonyms":["NSC-758386","Stangyl","Trimipramine maleate"],"crossReferences":{"DailyMed":["trimipramine%20maleate"],"PubChem":["144204000","170465260","26732627","26747677","26747678","50107079","50107080","50107081"],"chEBI":["35030"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200973","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1","inchiKey":"UOACKFBJUYNSLK-XRKIENNPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL CYPIONATE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Depo","Depo-estradiol","Estradiol cypionate"],"synonyms":["Estradiol 17.beta.-cyclopentanepropanoate","Estradiol cipionate","Estradiol cypionate","NSC-3354"],"crossReferences":{"DailyMed":["estradiol%20cypionate"],"PubChem":["144203554","144205884","144212135","170464789","46500620","69855"],"drugbank":["DB13954"],"chEBI":["34745"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","MONDO_0100096","MONDO_0001410","EFO_0004266","EFO_0003854","MONDO_0007254","EFO_1000096","EFO_0003882","HP_0030016","EFO_0003922"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 9 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201089","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"SPCKHVPPRJWQRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENHYDRAMINE CITRATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL657","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphenhydramine","Diphenhydramine citrate","Diphenhydramine laurylsulfate","Diphenhydramine tannate"],"crossReferences":{"DailyMed":["diphenhydramine%20citrate"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0006928","HP_0000989","HP_0012735","EFO_0003958","EFO_0009516","HP_0001742","EFO_0004698","EFO_0003843","EFO_0007214","HP_0002018","MONDO_0005277","HP_0002017","EFO_0003938","HP_0002013","EFO_0009847","EFO_0003956"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 14 approved and 2 investigational indications."}
{"id":"CHEMBL1201189","canonicalSmiles":"[13NH3]","inchiKey":"QGZKDVFQNNGYKY-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIA N 13","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1160819","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ammonia n 13"],"synonyms":["((sup 13)n)ammonia","13n","Ammonia n 13","Ammonia n-13","Ammonia, n-13","Ammonia-(sup 13)n"],"crossReferences":{"DailyMed":["ammonia%20n-13"],"drugbank":["DB09326"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2007 and is indicated for coronary artery disease."}
{"id":"CHEMBL1201321","canonicalSmiles":"N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1","inchiKey":"UFIVBRCCIRTJTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFENOXIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acscn-9168","Difenoxin","Diphenoxylate related compound a","Diphenoxylic acid","IDS-ND-007","Lyspafen","MCN-JR-15,403-11","Mcn-jr 15403-11","R 15,403 [AS HYDROCHLORIDE]","R-15403"],"crossReferences":{"DailyMed":["difenoxin%20hydrochloride"],"Wikipedia":["Difenoxin"],"drugbank":["DB01501"],"chEBI":["4534"]},"childChemblIds":["CHEMBL1200599"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0004798"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978."}
{"id":"CHEMBL1201322","canonicalSmiles":"CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1","inchiKey":"IOYZYMQFUSNATM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THONZONIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Thonzonium cation","Thonzonium ion","Tonzonium"],"crossReferences":{"PubChem":["11112412"],"drugbank":["DB09552"]},"childChemblIds":["CHEMBL1200883"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201406","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C[C@@H](O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"JYILPERKVHXLNF-QMNUTNMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYNODIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethynodiol"],"crossReferences":{"drugbank":["DB13866"],"chEBI":["50785"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201562","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON BETA-1A","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avonex","Neoferon","Rebif"],"synonyms":["Interferon beta-1a","SNG-001","SNG001","Sng001"],"crossReferences":{"DailyMed":["interferon%20beta-1a"],"DrugCentral":["5139"],"Wikipedia":["Interferon_beta-1a"]},"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000868","MONDO_0100130","EFO_0003929","EFO_0000384","EFO_0003106","MONDO_0100096","MONDO_0005301","EFO_0000712","MONDO_0004975","MONDO_0004979","EFO_1001373","EFO_0000341","EFO_0007328","EFO_0003047"],"count":15},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for multiple sclerosis and has 12 investigational indications."}
{"id":"CHEMBL1201774","canonicalSmiles":"C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1","inchiKey":"FNKQXYHWGSIFBK-RPDRRWSUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPROPTERIN","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["6r-bh4","Dapropterin","Daproterin","R-thbp","Sapropterin","Tetrahydrobiopterin"],"crossReferences":{"DailyMed":["sapropterin%20dihydrochloride"],"Wikipedia":["Tetrahydrobiopterin"],"drugbank":["DB00360"],"chEBI":["59560"]},"childChemblIds":["CHEMBL1201775","CHEMBL1515624"],"linkedTargets":{"rows":["ENSG00000171759"],"count":1},"linkedDiseases":{"rows":["MONDO_0043579","MONDO_0005090","EFO_0001361","Orphanet_716","Orphanet_232","Orphanet_238583","EFO_0001645","EFO_0003758","MONDO_0043771","EFO_0003876","EFO_1001461","EFO_0000666","EFO_0000537","EFO_0001422","HP_0012664","Orphanet_510","EFO_0003144","EFO_0003884","MONDO_0004975","EFO_0000341","EFO_0005411","EFO_0004265"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for hyperphenylalaninemia and phenylketonuria and has 17 investigational indications."}
{"id":"CHEMBL1229937","canonicalSmiles":"O=C(CO)CO","inchiKey":"RXKJFZQQPQGTFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROXYACETONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitadye"],"synonyms":["Dihydroxyacetone","FEMA NO. 4033","NSC-24343"],"crossReferences":{"Wikipedia":["Dihydroxyacetone"],"drugbank":["DB01775"],"chEBI":["16016"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1230244","canonicalSmiles":"Nc1c(C(=O)O)ccc(Cl)c1O","inchiKey":"VWEPFJPQZFIOAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230244","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04598"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232111","canonicalSmiles":"C#CCN(C)CC1=Cc2ccccc2Oc2ccccc21","inchiKey":"QLMMOGWZCFQAPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMIGAPIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cgp-3466","Omigapil"],"crossReferences":{"PubChem":["174006533"],"drugbank":["DB12879"],"chEBI":["41778"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL134","canonicalSmiles":"Clc1cccc(Cl)c1N=C1NCCN1","inchiKey":"GJSURZIOUXUGAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLONIDINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Catapres","Catapres-tts-1","Catapres-tts-2","Catapres-tts-3","Clonidine","Nexiclon xr"],"synonyms":["Catapres","Catarpres-tts","Clonidine","Clonidine extended release","Clorpres","Combipres","Duraclon","ST-155-BS","ST-155BS"],"crossReferences":{"DailyMed":["clonidine","clonidine%20hydrochloride"],"PubChem":["104171138","11110984","11110985","11113648","144203669","170464900","26751841","90341662"],"Wikipedia":["Clonidine"],"drugbank":["DB00575"],"chEBI":["3757"]},"childChemblIds":["CHEMBL1705"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0004240","EFO_1001139","EFO_0002610","EFO_0003777","EFO_0000401","EFO_0005252","MONDO_0007254","EFO_0009267","EFO_0000274","EFO_0002950","EFO_0007191","EFO_1000783","MONDO_0005277","EFO_0000289","EFO_0009514","HP_0001385","EFO_0003144","EFO_1000645","MONDO_0005299","EFO_0004616","HP_0003419","EFO_0005799","EFO_0005230","EFO_1001904","EFO_0005762","EFO_0003888","EFO_0000616","EFO_0003756","HP_0002024","EFO_0005323","EFO_0009085","EFO_0001358","EFO_0000319","EFO_0003843","EFO_1000971","EFO_0000537","EFO_0000311","HP_0000713","EFO_0003890","Orphanet_230","EFO_0004895","EFO_0004273","EFO_0009523","EFO_0005611","EFO_0000516","MONDO_0043510","MONDO_0005178","EFO_0000668","HP_0000023"],"count":49},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 7 approved and 26 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1447476","canonicalSmiles":"[Na+].[Na+].[O-]c1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1[O-]","inchiKey":"FNYZFZRGBBCWBI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BITHIONOLATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL290106","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"],"year":1967},"tradeNames":[],"synonyms":["Bithionol sodium salt","Bithionolate sodium","Sodium bithionolate","Sodium bitionolate","Vancide bn"],"crossReferences":{"PubChem":["144209989","26747892","26747893"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1967 due to Dermatological toxicity."}
{"id":"CHEMBL1463","canonicalSmiles":"Nc1[nH]c(=O)ncc1F","inchiKey":"XRECTZIEBJDKEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUCYTOSINE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alcobon","Ancoban","Ancobon","Ancotil","Flourocytosine","Flucytosine","Fluorocytosine"],"synonyms":["Flucytosine","Flucytosinum","NSC-103805","RO 2-9915","RO-2-9915","RO-29915"],"crossReferences":{"DailyMed":["flucytosine"],"PubChem":["11112505","144204066","170465407","174006933","405592","56424024","8139861"],"Wikipedia":["Flucytosine"],"drugbank":["DB01099"],"chEBI":["5100"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 3 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL151062","canonicalSmiles":"C[C@@H](O)c1ccccc1","inchiKey":"WAPNOHKVXSQRPX-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1-Phenyl-Ethanol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Phenyl-Ethanol"],"crossReferences":{"drugbank":["DB04784"],"chEBI":["45616"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL155265","canonicalSmiles":"O=[N+]([O-])c1cc2nc(O)c(O)nc2cc1[N+](=O)[O-]","inchiKey":"RWVIMCIPOAXUDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DNQX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNQX"],"crossReferences":{"PubChem":["50104334","90341758"],"drugbank":["DB03759"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1624","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O","inchiKey":"XUIIKFGFIJCVMT-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOTHYROXINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["L-thyroxine","Levothyroxin","Levothyroxine","NSC-36397","Synthetic levothyroxine","Thyroxine, l-"],"crossReferences":{"DailyMed":["levothyroxine%20sodium"],"PubChem":["144205654","144212473","170465450","26757755","8139892"],"Wikipedia":["Levothyroxine"],"drugbank":["DB00451"],"chEBI":["18332"]},"childChemblIds":["CHEMBL3989492","CHEMBL2103741","CHEMBL3989736"],"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_0006859","MONDO_0002108","EFO_0004283","EFO_1002017","EFO_0003843","EFO_0004237","Orphanet_309005","EFO_0002950","Orphanet_442","EFO_0000289","EFO_0002690","EFO_0002892","EFO_1001062","EFO_0000400","EFO_1000931","EFO_0004705"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 5 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743061","drugType":"Antibody","blackBoxWarning":false,"name":"RAFIVIRUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-57","Rafivirumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1874002","canonicalSmiles":"C/C(=C(/CCOC(=O)C(C)C)SS/C(CCOC(=O)C(C)C)=C(\\C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N","inchiKey":"CKHJPWQVLKHBIH-GPAWKIAZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1874002","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50112710"],"drugbank":["DB13416"],"chEBI":["31290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189938","canonicalSmiles":"COc1ccc(NC2=C(c3ccccc3)C(=O)N(Cc3ccccc3)C2=O)cc1","inchiKey":"HLZMYWLMBBLASX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL189938","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08063"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL191896","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(=O)OCC(O)COP(=O)([O-])O.[Na+]","inchiKey":"XGRLSUFHELJJAB-RRABGKBLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEOYL","maximumClinicalTrialPhase":2,"parentId":"CHEMBL189959","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oleoyl"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1944698","canonicalSmiles":"CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1","inchiKey":"VXBAJLGYBMTJCY-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOTIRACICLIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EX45","Ex 45","SB-1317","SB1317","Sb-1317 free base","TG02","Tg-02","Tg02","Zotiraciclib"],"childChemblIds":["CHEMBL4298173"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000123374","ENSG00000134058","ENSG00000136807","ENSG00000170312","ENSG00000122025"],"count":6},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000182","EFO_1001465","EFO_1000657","EFO_0000519"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2041980","canonicalSmiles":"CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)c2)cc1","inchiKey":"RTJQABCNNLMCJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MMV-390048","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.367.891F","MMV-048","MMV-390048","MMV048","Mmv-390048"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2096660","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMARIUM SM 153 LEXIDRONAM PENTASODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110561","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Quadramet"],"synonyms":["153sm","CYT-424","Samarium (153 sm) lexidronam pentasodium","Samarium (153Sm) Lexidronam","Samarium (153Sm) Lexidronam Pentasodium","Samarium (153sm) lexidronam","Samarium sm 153 lexidronam pentasodium","Samarium sm 153 lexidronam pentasodium salt","Samarium sm-153 lexidronam pentasodium","Sm-153 edtmp pentasodium"],"crossReferences":{"DailyMed":["samarium%20sm-153%20lexidronam%20pentasodium"],"DrugCentral":["4533"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL2105619","canonicalSmiles":"CC[C@H](OC(C)=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"XBMIVRRWGCYBTQ-GCJKJVERSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETACETYLMETHADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9607","Betacetylmethadol","IDS-NB-003"],"crossReferences":{"drugbank":["DB01522"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105676","canonicalSmiles":"CC(OC(=O)c1ccc(Cc2c([O-])c3ccccc3oc2=O)cc1)(C(F)(F)F)C(F)(F)F.[Na+]","inchiKey":"DTAROZQXDYVCQR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TECARFARIN SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105664","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["60 TIS 99","60-TIS-99","ATI-5923","ATI-5923 SODIUM SALT","Tecarfarin sodium"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107572","canonicalSmiles":"COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1.Cl","inchiKey":"YJXUXANREVNZLH-PFEQFJNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECALCET HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL292376","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Norcalcin","Norcalin"],"synonyms":["KRN-568","NPS R-568","NPS-R-568","NPSR-568","R-568","Tecalcet hcl","Tecalcet hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107829","canonicalSmiles":"Cl.NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1","inchiKey":"BPZWRYOUJMDQSY-PKLMIRHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMIXUSTAT HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2107821","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Acu-4429 hcl"],"synonyms":["ACU-4429 HCL","ACU-4429 HYDROCHLORIDE","Emixustat hydrochloride"],"linkedTargets":{"rows":["ENSG00000116745"],"count":1},"linkedDiseases":{"rows":["EFO_0009322"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107846","drugType":"Protein","blackBoxWarning":false,"name":"DULANERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-951","APO2L/TRAIL","B lymphocyte stimulator (human)","Dulanermin"],"linkedTargets":{"rows":["ENSG00000104689","ENSG00000120889"],"count":2},"linkedDiseases":{"rows":["EFO_1001480","EFO_0005952","EFO_0003060","EFO_1001951"],"count":4},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108722","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGADRICASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pegadricase","Pegsiticase","SEL-037","Sel-037","URICASE-PEG 20","URICASE-PEG-20","URICASE-PEG20"],"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109036","drugType":"Antibody","blackBoxWarning":false,"name":"IGOVOMAB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inadmacis-125"],"synonyms":["Igovomab","OC-125"],"description":"Antibody drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2109281","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7600","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DMOT4039A","RG-7600"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109377","drugType":"Antibody","blackBoxWarning":false,"name":"PAMREVLUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FG-3019","Pamrevlumab"],"linkedTargets":{"rows":["ENSG00000118523"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","EFO_0002618","EFO_1000044","MONDO_0100096","EFO_0000768","EFO_0004236","EFO_0000400","EFO_0004239"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109381","drugType":"Antibody","blackBoxWarning":false,"name":"BHQ-880","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BHQ-880","BHQ880","Bhq-880"],"linkedTargets":{"rows":["ENSG00000107984"],"count":1},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109386","drugType":"Antibody","blackBoxWarning":false,"name":"CHTNT-1 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHTNT-1","Chtnt-1 131i"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109450","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-811","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-811","Amg-811"],"linkedTargets":{"rows":["ENSG00000111537"],"count":1},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109549","drugType":"Antibody","blackBoxWarning":false,"name":"J591","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUJ-591","HUJ591-GS","J591","Rosopatamab"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109623","drugType":"Antibody","blackBoxWarning":false,"name":"STX-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["STX-100","Stx-100"],"linkedTargets":{"rows":["ENSG00000138448","ENSG00000115221"],"count":2},"linkedDiseases":{"rows":["EFO_0000768"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109882","canonicalSmiles":"O=[Si](O)O[Si](O)(O)O[Si](=O)O","inchiKey":"NPEYATQABYMBPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRISILICATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL2096633"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL2110829","canonicalSmiles":"Cc1cccc(Cc2c[nH]cn2)c1C","inchiKey":"RHDJRPPFURBGLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DETOMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Detomidine"],"crossReferences":{"drugbank":["DB11556"]},"childChemblIds":["CHEMBL2106210"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL212218","canonicalSmiles":"Cc1cc(S(=O)(=O)c2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])c(Cl)cc1Cl","inchiKey":"INAZPZCJNPPHGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL212218","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07620"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220320","canonicalSmiles":"O=C(NCc1ccccc1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1","inchiKey":"PDJZASCRQRBYQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220320","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07010"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219640","canonicalSmiles":"[Cl-].[Cl-].[Sr+2]","inchiKey":"AHBGXTDRMVNFER-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM CHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Strontium chloride"],"crossReferences":{"DailyMed":["strontium%20chloride%20sr-89"],"drugbank":["DB13987"],"chEBI":["36383"]},"childChemblIds":["CHEMBL1200625","CHEMBL2105878","CHEMBL1909080"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for metastasis and has 1 investigational indication."}
{"id":"CHEMBL222280","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br","inchiKey":"WOVKYSAHUYNSMH-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROXURIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Broxuridine","NSC-38297"],"crossReferences":{"PubChem":["144204567","144207304","170465870","17389223","29215103","50105447","50105448","56463513","90341500"],"Wikipedia":["Bromodeoxyuridine"],"drugbank":["DB12028"],"chEBI":["472552"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL226267","canonicalSmiles":"COc1ccc(-c2sc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1","inchiKey":"MCGDSOGUHLTADD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARZOXIFENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arzoxifene","LY353381"],"crossReferences":{"Wikipedia":["Arzoxifene"],"drugbank":["DB06249"]},"childChemblIds":["CHEMBL2105949"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","Orphanet_145","EFO_0003854","MONDO_0008170","MONDO_0011962","MONDO_0007254","MONDO_0002087","EFO_0003882"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL231068","canonicalSmiles":"O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1","inchiKey":"PPRRDFIXUUSXRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLIBANSERIN","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Addyi"],"synonyms":["BIMT 17","BIMT 17 BS","BIMT-17","BIMT-17-BS","Ectris","Flibanserin"],"crossReferences":{"DailyMed":["flibanserin"],"Wikipedia":["Flibanserin"],"drugbank":["DB04908"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for sexual dysfunction and mental or behavioural disorder and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2364655","drugType":"Antibody","blackBoxWarning":false,"name":"EVOLOCUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Repatha","Repatha sureclick"],"synonyms":["AMG-145","Evolocumab"],"crossReferences":{"DailyMed":["evolocumab"],"DrugCentral":["5000"]},"linkedTargets":{"rows":["ENSG00000169174"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0008585","EFO_0003144","MONDO_0008903","EFO_0000712","EFO_0003884","Orphanet_391665","EFO_0008586","HP_0002140","HP_0003124","EFO_0001645","EFO_0000556","EFO_0000319","EFO_0004911","EFO_0003060","Orphanet_309005","EFO_0002615","HP_0100806","MP_0001845","HP_0012664","MONDO_0100096","MONDO_0021187","Orphanet_412","Orphanet_79211","EFO_0000612","EFO_0003781","MONDO_0005148","EFO_0000519","EFO_0005672","EFO_0004265"],"count":30},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 6 approved and 11 investigational indications."}
{"id":"CHEMBL2365712","canonicalSmiles":"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"SEALOBQTUQIVGU-QNIJNHAOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2365712","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11273"],"chEBI":["59909"]},"childChemblIds":["CHEMBL2356227"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2442750","canonicalSmiles":"Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1","inchiKey":"YOPFAMROKXHVCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QAV680","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NVP-QAV680","Nvp-qav-680","QAV680","QAV690 FREE ACID","Qav-680","Qav-690 free acid","Qav680"],"crossReferences":{"drugbank":["DB11658"]},"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0004979","EFO_0003956"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL247767","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C1CCNC(=N)N1)C(=O)N[C@H](C=O)Cc1ccccc1","inchiKey":"MRXDGVXSWIXTQL-HYHFHBMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHYMOSTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chymostatin"],"crossReferences":{"drugbank":["DB01683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253608","canonicalSmiles":"Cc1cc(C(=O)Nc2cc(Cl)cc(N3CCCCC3)c2)cc(C)c1OCCN","inchiKey":"JDYIYIRPQKMWMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253608","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08697"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262103","canonicalSmiles":"CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)OC)[C@@H](C)CC","inchiKey":"XGWSRLSPWIEMLQ-YTFOTSKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL262103","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756809"],"drugbank":["DB07223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL265758","canonicalSmiles":"Nc1nc(O)c2nn(-c3cccc(C(=O)O)c3)nc2n1","inchiKey":"KNLLRZNGRRRPEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL265758","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01906"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275311","canonicalSmiles":"C/C(=C\\c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C","inchiKey":"FOIVPCKZDPCJJY-JQIJEIRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Ro-137410","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ro-137410"],"crossReferences":{"PubChem":["11111877","11113689","124881633","251919756","26751878","26751880","26751881","50104564","56463204","85231254","90341737"],"drugbank":["DB02877"],"chEBI":["75261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282575","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"UYIFTLBWAOGQBI-BZDYCCQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRADIOL BENZOATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benztrone","Progynon b oleoso"],"synonyms":["Benzestrofol","Benzogynestryl","Beta-estradiol benzoate","Difolliculin","Estradiol 3-benzoate","Estradiol benzoate","Estradiol monobenzoate","Follidrin","NSC-9566","Oestradiol benzoate"],"crossReferences":{"PubChem":["144204419","29214996","855530"],"drugbank":["DB13953"],"chEBI":["77006"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL295971","canonicalSmiles":"CO/C=C\\[C@H](N)C(=O)O","inchiKey":"HLOPMQJRUIOMJO-SWOZAWMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL295971","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03611"],"chEBI":["40719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL311226","canonicalSmiles":"O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O","inchiKey":"JDVVGAQPNNXQDW-TVNFTVLESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASTANOSPERMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Castanospermine","NSC-625381"],"crossReferences":{"PubChem":["11532892","26751872","26751873"],"Wikipedia":["Castanospermine"],"drugbank":["DB01816"],"chEBI":["27860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3121539","canonicalSmiles":"CC1=CC[C@H](C(=O)N(c2cc(C#CC(C)(C)C)sc2C(=O)O)[C@H]2CC[C@](O)(CO[C@H]3CCOC3)CC2)CC1","inchiKey":"MUICUPWICXUNRS-GDCCIXDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADALBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gs-9669","Radalbuvir"],"crossReferences":{"drugbank":["DB12065"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137315","canonicalSmiles":"Cn1c(C2(NC(=O)c3ccc4c(C5CCCC5)c(-c5ncc(Br)cn5)n(C)c4c3)CCC2)nc2ccc(/C=C/C(=O)[O-])cc21.[Na+]","inchiKey":"YJADTGFGJMFOLM-KJEVSKRMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DELEOBUVIR SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2403318","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 207127 NA","BI-207127 NA","BI-207127 SODIUM SALT","BI-207127NA","Deleobuvir sodium"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3186112","canonicalSmiles":"OCC(CO)(CO)CO","inchiKey":"WXZMFSXDPGVJKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186112","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209119","144213878"],"drugbank":["DB13526"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188355","canonicalSmiles":"C/C=C(C(=C/C)/c1ccc(OC(C)=O)cc1)\\c1ccc(OC(C)=O)cc1","inchiKey":"YWLLGDVBTLPARJ-OXAZHYLESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3188355","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170466708"],"drugbank":["DB14668"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325372","canonicalSmiles":"COC(=O)c1ccc(O)cc1","inchiKey":"LXCFILQKKLGQFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-218","E218","FEMA NO. 2710","INS NO.218","INS-218","Killitol","Methyl p-hydroxybenzoate","Methyl p-oxybenzoate","Methyl paraben","Methyl paraben (e218)","Methyl parahydroxybenzoate","Methylis hydroxybenzoas","Methylparaben","Methylparaben e218","Moldex","NSC-3827","NSC-406127","P-hydroxybenzoic methyl ester","Preserval m","Tegosept m"],"crossReferences":{"PubChem":["144205169","144209516","144210329","170465480","26754470","50085960"],"Wikipedia":["Methylparaben"],"drugbank":["DB14212"],"chEBI":["31835"]},"childChemblIds":["CHEMBL2106903"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3408947","canonicalSmiles":"COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2","inchiKey":"DADASRPKWOGKCU-FVTQAUBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CFI-400945","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297462"],"linkedTargets":{"rows":["ENSG00000142731"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","MONDO_0008315","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL34474","canonicalSmiles":"COC(=O)C(C)Oc1ccc(Oc2ccc(Cl)cc2Cl)cc1","inchiKey":"BACHBFVBHLGWSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICLOFOP-METHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211096","26757265"],"drugbank":["DB13918"],"chEBI":["4510"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544949","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(N)=O","inchiKey":"VUYRSKROGTWHDC-HZGLMRDYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CTCE-9908","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CTCE 9908","Ctce-9908"],"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3544977","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1[C@H](c2nc3cc(-c4cc5ccc4CCc4ccc(c(-c6ccc7[nH]c([C@@H]8C[C@@H]9CCCC[C@@H]9N8C(=O)[C@@H](NC(=O)OC)C(C)C)nc7c6)c4)CC5)ccc3[nH]2)C[C@@H]2CCCC[C@@H]21)C(C)C","inchiKey":"LSYBRGMTRKJATA-IVEWBXRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODALASVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACH-0143102","ACH-3102","Odalasvir"],"crossReferences":{"drugbank":["DB13041"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545063","canonicalSmiles":"C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.CS(=O)(=O)O","inchiKey":"FUKSNUHSJBTCFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSIMERTINIB MESYLATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3353410","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tagrisso"],"synonyms":["AZD-9291 MESYLATE","AZD9291 mesylate","Mereletinib mesilate","Mereletinib mesylate","Osimertinib mesilate","Osimertinib mesylate"],"crossReferences":{"DailyMed":["osimertinib%20mesylate"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["MONDO_0008903","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for non-small cell lung carcinoma."}
{"id":"CHEMBL3545166","canonicalSmiles":"CS(=O)(=O)N(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1","inchiKey":"IQQBRKLVEALROM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DRINABANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ave1625","Drinabant"],"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545394","drugType":"Small molecule","blackBoxWarning":false,"name":"DRF-10945","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Drf-10945"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL360376","canonicalSmiles":"O=C(CSc1nc(O)cc(C(F)(F)F)n1)N1CCCCC1","inchiKey":"UDBHGUOSOKOIAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360376","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3668014","canonicalSmiles":"COc1cc(F)c(-n2c(=O)[nH]c3csc(C(=O)O)c3c2=O)cc1OCc1c(OC)ccc(F)c1F","inchiKey":"BMAAMIIYNNPHAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINZAGOLIX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KLH-2109","Klh-2109","Linzagolix","OBE-2109","OBE2109"],"childChemblIds":["CHEMBL4298171"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001065","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707342","canonicalSmiles":"O=C([O-])c1ccccc1O.[K+]","inchiKey":"FRMWBRPWYBNAFB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Potassium salicylate","Salicylic acid potassium salt"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3833346","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"TOFERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-067","BIIB067","Biib067","ISIS-SOD1Rx","Tofersen"],"linkedTargets":{"rows":["ENSG00000142168"],"count":1},"linkedDiseases":{"rows":["MONDO_0004976"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3833378","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O.CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCN(CCO)CC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"MEGKRPMNPGTIIG-VNYBMUHKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENIMEPICYCLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Criseocil","Geotricyn","Mepicycline penicillinate","Penetracyne","Penimepicycline"],"crossReferences":{"DrugCentral":["2084"],"drugbank":["DB13264"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989480","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Mg+2].[Mg+2].[Mg+2]","inchiKey":"PLSARIKBYIPYPF-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citramag","Mag cit","Mag diasporal 300","Magcit"],"synonyms":["Magnesium citrate","NSC-83517"],"crossReferences":{"drugbank":["DB11110"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation disorder and constipation and has 4 investigational indications."}
{"id":"CHEMBL3989509","canonicalSmiles":"CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C.CC(O)C(=O)O","inchiKey":"QNLDTXPVZPRSAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTAZOCINE LACTATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL100116","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Talwin"],"synonyms":["Pentazocine lactate","Talwin (lactate)"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989724","canonicalSmiles":"CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl","inchiKey":"ZIIJJOPLRSCQNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLURAZEPAM HYDROCHLORIDE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL968","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dalmane","Flurazepam hydrochloride"],"synonyms":["Flurazepam","Flurazepam dihydrochloride","Flurazepam hydrochloride","Flurazepam hydrochloride civ","NSC-78559","RO 5-6901","RO-5-6901"],"crossReferences":{"DailyMed":["flurazepam%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970 and is indicated for insomnia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989845","canonicalSmiles":"CN(C)CCCN1c2ccccc2CCc2ccccc21.CN(C)CCCN1c2ccccc2CCc2ccccc21.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"BPQZYOJIXDMZSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IMIPRAMINE PAMOATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL11","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imipramine pamoate","Tofranil-pm"],"synonyms":["Imipramine embonate","Imipramine pamoate"],"crossReferences":{"DailyMed":["imipramine%20pamoate"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["MONDO_0024290"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973 and is indicated for enuresis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989986","drugType":"Antibody","blackBoxWarning":true,"name":"RAVULIZUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ultomiris"],"synonyms":["ALXN-1210","ALXN1210","Ravulizumab","Ravulizumab-cwvz"],"crossReferences":{"DailyMed":["ravulizumab-cwvz"]},"linkedTargets":{"rows":["ENSG00000106804"],"count":1},"linkedDiseases":{"rows":["EFO_0004610","Orphanet_2134","MONDO_0001549","EFO_0000398","EFO_0004256","EFO_0007541","EFO_0004991","EFO_1000637","EFO_0000540","MONDO_0004976","Orphanet_183589","Orphanet_447"],"count":12},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL419213","canonicalSmiles":"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O","inchiKey":"CZRQXSDBMCMPNJ-ZUIPZQNBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LISINOPRIL","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acemin","Carace","Lisinopril","Lisopress","Prinivil","Qbrelis","Zestril"],"synonyms":["Lisinopril","Lisinopril dihydrate","Lisinopril hydrate","MK-521","Ranolip"],"crossReferences":{"PubChem":["11113057","170464907"],"chEBI":["6503"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000712","EFO_0000373","EFO_0000612","EFO_0000319","EFO_0000400","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 7 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297205","drugType":"Small molecule","blackBoxWarning":false,"name":"PADOPORFIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Padoporfin","WST-09","WST09","Wst09"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297262","canonicalSmiles":"CCCCCCCCCCCCCCCCCCCC(=O)N[C@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](O)[C@@H]1[C@@H]2C[C@H](O)[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(=O)O","inchiKey":"SHKXZIQNFMOPBS-OOMQYRRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARAMCHOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arachidyl amido cholanoic acid","Aramchol","C20-fabac"],"crossReferences":{"drugbank":["DB11860"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297395","name":"CHEMBL4297395","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11848"]}}
{"id":"CHEMBL4297467","canonicalSmiles":"Nc1ccc(/C=C/C(=O)NCc2cc3cc(-c4ccc(C(=O)N5CCC(F)(F)CC5)cc4)cc(-c4ccc(F)cc4)c3o2)cn1","inchiKey":"MRFOPLWJZULAQD-SWGQDTFXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KPT-9274","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KPT-9274","Kpt 9274","Kpt-9274","Pak4-in-1"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297692","drugType":"Unknown","blackBoxWarning":false,"name":"ALX-0171","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX-0171","ALX0171","Alx-0171","Gontivimab"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297698","drugType":"Unknown","blackBoxWarning":false,"name":"AVI-7537","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avi-7537"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297768","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"IDRABIOTAPARINUX SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idrabiotaparinux sodium"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297920","drugType":"Antibody","blackBoxWarning":false,"name":"TIMOLUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTT-1023","Btt-1023","Timolumab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298168","canonicalSmiles":"CC(C)[C@@H](C)[C@@]1(C)CC[C@]2(C)[C@H]3CC[C@H]4[C@@]5(C)COC[C@@]4(C[C@@H](n4ncnc4-c4ccncc4)[C@@H]5OC[C@](C)(N)C(C)(C)C)C3=CC[C@@]2(C)[C@@H]1C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"WKIRTJACGBEXBZ-FQGZCCSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBREXAFUNGERP CITRATE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4297513","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brexafemme"],"synonyms":["Ibrexafungerp citrate","SCY-078 citrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for vulvovaginal candidiasis."}
{"id":"CHEMBL43184","canonicalSmiles":"Nc1c2ccccc2nc2ccccc12","inchiKey":"XJGFWWJLMVZSIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINACRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-Aminoacridine","Aminoacridine","NSC-13000"],"crossReferences":{"PubChem":["26748404","26748405","50107395"],"Wikipedia":["9-Aminoacridine"],"drugbank":["DB11561"],"chEBI":["74789"]},"childChemblIds":["CHEMBL1308088","CHEMBL1330022"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL448343","canonicalSmiles":"NC[C@@H](F)C[PH](=O)O","inchiKey":"LJNUIEQATDYXJH-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LESOGABERAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3355","AZD3355","Azd3355","Lesogaberan"],"crossReferences":{"Wikipedia":["Lesogaberan"],"drugbank":["DB11920"]},"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["EFO_0003948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594479","drugType":"Unknown","blackBoxWarning":false,"name":"IRX-2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytokine-based biologic agent irx-2","Irx 2","Irx-2"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4594576","drugType":"Unknown","blackBoxWarning":false,"name":"MGC-018","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGC-018","MGC018","Mgc-018","Mgc018"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650306","drugType":"Protein","blackBoxWarning":false,"name":"PP-F11N LUTETIUM LU-177","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4651038","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(177lu)pp-f11n","177lu-pp-f11n","Lutetium lu 177 pp-f11n","PP-F11N LUTETIUM LU-177","PP-F11N(177LU)","Pp-f11n lutetium lu-177"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650309","canonicalSmiles":"CC(=O)O.N=C(NC(=N)N1CCCC1)Nc1ccc(OC(F)(F)F)cc1","inchiKey":"AGFDCTOLSXWRDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IM-156","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4650733","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HL-156A","HL156A","HL271 ACETATE","IM-156","IM156","Im-156","Im156"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650332","canonicalSmiles":"O=C([C@H](CO)c1ccccc1)N1CC2=C(C1)CN(S(=O)(=O)c1cnc3c(c1)OCCO3)C2","inchiKey":"KZFFYEPYCVDOGE-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETAVOPIVAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etavopivat","FT-4202","Ft-4202"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650449","drugType":"Antibody","blackBoxWarning":false,"name":"GARIVULIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB A333","BGB-A333","Bgb-a333","Garivulimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL47302","canonicalSmiles":"Cc1nc(C)c(-c2ccnc(N)n2)s1","inchiKey":"CTFDMGIBHFQWKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL47302","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02091"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL475814","canonicalSmiles":"Cc1cc(Nc2ccc3cc4ccccc4cc3c2)n2ncnc2n1","inchiKey":"OXYDLVAOXASTMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL475814","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478","canonicalSmiles":"Clc1cccc(N2CCNCC2)c1","inchiKey":"VHFVKMTVMIZMIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROPHENYLPIPERAZINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-M-Chlorophenyl Piperazine Metabolite","Chlorophenylpiperazine","mCPP"],"crossReferences":{"PubChem":["104171132","11110958","11113750","124879663","144203661","170466760","26751928","50104608"],"Wikipedia":["Meta-Chlorophenylpiperazine"],"drugbank":["DB12110"],"chEBI":["10588"]},"childChemblIds":["CHEMBL1256321","CHEMBL1256029"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4802137","canonicalSmiles":"O=S1(=O)c2ccc(F)cc2Oc2cc(OCC(F)(F)F)ccc21","inchiKey":"PDIMOTRDGUQMNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CX-157","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX-157","CX157","Cx-157","Cx157","KP157","Tririma","Tyrima"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802213","drugType":"Protein","blackBoxWarning":false,"name":"PEGLOXENATIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PEX-168","PEX168","Peg loxenatide","Peg-40 kd-loxenatide","Pegloxenatide","Pex168"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL486214","canonicalSmiles":"COC(=O)c1ccc(O)c(OC)c1","inchiKey":"BVWTXUYLKBHMOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL VANILLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyl Vanillate","Methylvanillate"],"crossReferences":{"drugbank":["DB08711"],"chEBI":["46477"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489411","canonicalSmiles":"CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1","inchiKey":"MQHLMHIZUIDKOO-AYHJJNSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOROLFINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loceryl","Loceryl curanail","Omicur"],"synonyms":["Amorolfine","Amorolfine (as hydrochloride)","Amorolfine hcl","Amorolfine hydrochloride","RO 14-4767/000"],"crossReferences":{"PubChem":["144206074","170466078","50112777"],"Wikipedia":["Amorolfine"],"drugbank":["DB09056"],"chEBI":["599440"]},"childChemblIds":["CHEMBL4303363"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL492514","canonicalSmiles":"COc1ccc(C(=O)N/N=C/c2cc(Br)c(O)c(Br)c2O)cc1","inchiKey":"BMGXNERTVNWBJG-CNHKJKLMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL492514","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06978"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL493","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"OZVBMTJYIDMWIL-AYFBDAFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOCRIPTINE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parlodel"],"synonyms":["2-bromo-.alpha.-ergocryptine","Bromergocryptine","Bromocriptine","CB-154","Ergocryptine, 2-bromo-","SANDOZ 15-754"],"crossReferences":{"DailyMed":["bromocriptine%20mesylate"],"PubChem":["144204458","26751716","26755307","90340796"],"Wikipedia":["Bromocriptine"],"drugbank":["DB01200"],"chEBI":["3181"]},"childChemblIds":["CHEMBL1255752","CHEMBL1200503"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0002628","Orphanet_64739","EFO_0000545","EFO_1001757","EFO_0000232","EFO_0003847","EFO_0001073","MONDO_0001299","MONDO_0002146","EFO_0003890","EFO_1001485","MONDO_0005180","MONDO_0005147","MONDO_0004975","EFO_0007319","EFO_0009321","MONDO_0005148","EFO_0004215"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 7 approved and 7 investigational indications."}
{"id":"CHEMBL495727","canonicalSmiles":"O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1","inchiKey":"LOLPPWBBNUVNQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-9283","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-9283","AT9283","At 9283","At-9283"],"childChemblIds":["CHEMBL496311"],"linkedTargets":{"rows":["ENSG00000087586","ENSG00000096968","ENSG00000097007","ENSG00000178999","ENSG00000105639","ENSG00000122025"],"count":6},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0001378","EFO_0005952"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL549344","canonicalSmiles":"CCc1nc2c(N)nc3ccccc3c2n1CCCCNS(C)(=O)=O","inchiKey":"YZOQZEXYFLXNKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CPG-52852","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cpg-52852","PF-4878691"],"crossReferences":{"drugbank":["DB12476"]},"linkedTargets":{"rows":["ENSG00000196664"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000389","EFO_0000756"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL549385","canonicalSmiles":"O=C1/C(=N\\O)c2c(-c3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2","inchiKey":"SZYREAUDQRVVLV-DAFNUICNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549385","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08015"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL556417","canonicalSmiles":"Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC2)c1","inchiKey":"UCOAKFIVSAVHLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL556417","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14888"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58343","canonicalSmiles":"NCCCCN=C(N)N","inchiKey":"QYPPJABKJHAVHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AGMATINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agmatine"],"crossReferences":{"PubChem":["11110769","11113734","124879247","90341553"],"Wikipedia":["Agmatine"],"drugbank":["DB08838"],"chEBI":["17431"]},"childChemblIds":["CHEMBL1256618"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL608","canonicalSmiles":"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1","inchiKey":"FYPMFJGVHOHGLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROBUCOL","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bisbid","Lorelco","Lurselle","Probucol","Sinlestal"],"synonyms":["DH-581","NSC-652160","NSC-86225","Probucol"],"crossReferences":{"PubChem":["11112687","123183","124882521","144204156","170464772","26748484","50107410","8139943"],"Wikipedia":["Probucol"],"drugbank":["DB01599"],"chEBI":["8427"]},"linkedTargets":{"rows":["ENSG00000165029"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0003124","MONDO_0021187","EFO_0000401","MONDO_0002679","EFO_0000319","EFO_0004194","EFO_0004265"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL611","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC","inchiKey":"VCKUSRYTPJJLNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERAZOSIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hytrin","Terazosabb","Terazosin"],"crossReferences":{"DailyMed":["terazosin%20hydrochloride"],"PubChem":["174007477","50085853","855611","90340975"],"Wikipedia":["Terazosin"],"drugbank":["DB01162"],"chEBI":["9445"]},"childChemblIds":["CHEMBL1201091","CHEMBL3989562","CHEMBL1256665"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","MONDO_0005180","HP_0000726","EFO_0001645","HP_0000975","EFO_0000284","EFO_0000400","MONDO_0005148","EFO_0002615","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for benign prostatic hyperplasia and has 8 investigational indications."}
{"id":"CHEMBL75133","canonicalSmiles":"CC(/C=C/[C@@H]1C[C@]1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\\C(=O)O","inchiKey":"BOOOLEGQBVUTKC-NVQSDHBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRX-4204","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-194204","AGN194204","Irx-4204","KB-145960","NRX-194204","NRX194204","VTP-194204"],"crossReferences":{"drugbank":["DB11806"]},"linkedTargets":{"rows":["ENSG00000204231","ENSG00000143171","ENSG00000186350"],"count":3},"linkedDiseases":{"rows":["MONDO_0005180","MONDO_0008315","EFO_0003060","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL91829","canonicalSmiles":"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1","inchiKey":"ZCBUQCWBWNUWSU-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUBOXISTAURIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Arxxant"],"synonyms":["LY-333531","Ly-333531","Ruboxistaurin"],"crossReferences":{"PubChem":["50100106"],"Wikipedia":["Ruboxistaurin"],"drugbank":["DB11829"]},"childChemblIds":["CHEMBL432130"],"linkedTargets":{"rows":["ENSG00000166501"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0003144","MONDO_0005147","EFO_0003770","EFO_0009321","MONDO_0005148","EFO_0000400"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL99","canonicalSmiles":"CC(/C=C/C(=O)NO)=C\\[C@@H](C)C(=O)c1ccc(N(C)C)cc1","inchiKey":"RTKIYFITIVXBLE-QEQCGCAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHOSTATIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-300-I","ANTIBIOTIC A-300","GNF-Pf-1011","Trichostatin","Trichostatin(s)"],"crossReferences":{"PubChem":["26755794","26755795","46371223","96099520"],"Wikipedia":["Trichostatin_A"],"drugbank":["DB04297"],"chEBI":["46024"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
